Gadodiamide clinical trials
Also written Omniscan.
How each study uses gadodiamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the gadodiamide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 8 Jan 1993 · OMNISCAN · NDA 020123 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2003 (1)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2009 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses gadodiamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsRecruitingPhase 4GuerbetNCT04373564Written as GadodiamideHow we know
- A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arteries While Using GadodiamideCompletedPhase 3GE HealthcareNCT00209391Written as Gadodiamide InjectionHow we know
- A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using GadodiamideCompletedPhase 3GE HealthcareNCT00209443Written as Gadodiamide InjectionHow we know
- Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)CompletedPhase 4GE HealthcareNCT00908310Written as OmniscanHow we know
As the comparator · 1 — what is tested is compared with gadodiamide
Codes
What other systems call gadodiamide · ClinicalTrials.gg INT003522
- MeSH (NLM) C064925gadodiamideConfirmed NLM, Wikidata
- UNII (FDA) 84F6U3J2R6GADODIAMIDEConfirmed FDA, NLM, Wikidata
- RxNorm 41144Confirmed FDA, Wikidata
- Wikidata Q2031078gadodiamide hydrateConfirmed FDA, NLM, Wikidata
- Wikidata Q72479907GadodiamideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65795GadodiamideOne source FDA
- DrugBank DB00225One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C064925 | gadodiamide | Confirmed NLM, Wikidata |
| UNII (FDA) | 84F6U3J2R6 | GADODIAMIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 41144 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2031078 | gadodiamide hydrate | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q72479907 | Gadodiamide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65795 | Gadodiamide | One source FDA |
| DrugBank | DB00225 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.